Jon Congleton Mineralys Therapeutics, Inc. (MLYS) insider trading activity

Shares Held (Direct Ownership) 927K

11.64% 3M change

n/a 12M change

Total Value Held N/A

Jon Congleton Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 20 2024	SELL Open market or private sale	$175,246 $11.73 p/Share	14,940 Reduced 1.59%	926,958 Common Stock
Jun 18 2024	SELL Open market or private sale	$199,117 $11.99 p/Share	16,607 Reduced 1.73%	941,898 Common Stock
Jun 17 2024	SELL Open market or private sale	$217,633 $12.25 p/Share	17,766 Reduced 1.82%	958,505 Common Stock
Jun 14 2024	SELL Open market or private sale	$203,187 $12.52 p/Share	16,229 Reduced 1.64%	976,271 Common Stock
Jun 13 2024	SELL Open market or private sale	$509,103 $12.74 p/Share	39,961 Reduced 3.87%	992,500 Common Stock
Jun 12 2024	SELL Open market or private sale	$212,071 $12.77 p/Share	16,607 Reduced 1.58%	1,032,461 Common Stock
Nov 22 2023	BUY Open market or private purchase	$25,372 $5.97 p/Share	4,250 Added 0.4%	1,049,068 Common Stock

Sep 06 2023	BUY Open market or private purchase	$27,180 $12.08 p/Share	2,250 Added 0.21%	1,044,818 Common Stock
Aug 17 2023	BUY Open market or private purchase	$27,225 $12.1 p/Share	2,250 Added 0.22%	1,042,568 Common Stock
Aug 11 2023	BUY Open market or private purchase	$25,780 $12.89 p/Share	2,000 Added 0.19%	1,040,318 Common Stock

Chief Executive Officer

Radnor, PA

Receive a notification when an Institution or Guru buys or sells MLYS shares.

Notify only if

Value

Get notified when an Mineralys Therapeutics, Inc. insider buys or sells MLYS shares.

Notify only if

Operation

Value

Type

Receive news related to Mineralys Therapeutics, Inc.